Astaxanthin

Studies of astaxanthin in people

22 studies gave astaxanthin to people and measured what changed

What changedDesignPeopleSource

down: Decreases depressive symptomsHAM-D scores decreased by 10.9%

Randomized trial12 weeks100 peopleWomen55–60 yearsMidlife adults; Older adults; Postmenopausal women; Sedentary postmenopausal women with mild-to-moderate depressive symptomsExplore (New York, N.Y.), Nov 1, 2026

no change: Has no effect on HbA1c

Randomized trial8 weeks90 peoplewomen30 to 60 years oldWomen with T2DMScientific reports, Nov 17, 2025

up: Increases ventilatory anaerobic thresholdPLA 66.7 ± 4.7%, AX 73.8 ± 4.7%

down: Decreases interleukin-1β

Randomized trialfour weeks20 peoplemale34.5 ± 7.4 years oldHealthy, career male firefightersJournal of the International Society of Sports Nutrition, Nov 20, 2024

up: Increases retrieved oocytes

Randomized trialeight weeks60 peopleWomenage > 35 yearsInfertile patients with POR undergoing ARTJournal of ovarian research, Oct 31, 2024

down: Decreases TNF-alpha

no change: Has no effect on C-reactive protein

no change: Has no effect on body mass index

Randomized trial8 weeks56 peoplewomen18–40PCOS patientsJournal of cellular and molecular medicine, Jul 1, 2024

down: Decreases IL-6P < 0.01

up: Improves MII oocyte countP = 0.007

no change: Has no effect on clinical pregnancy

Randomized trial8 weeks44 peopleWomenPCOS undergoing ARTInflammopharmacology, Jun 25, 2024

down: Decreases arachidonic acid24 % drop

Randomized trial12 weeks68 peopleaged 40 to 65Patients with type II diabetesEXCLI journal, Apr 25, 2023

down: Decreases low-density lipoprotein-0.33 ± 0.11 mM, P < .05

down: Decreases fibrinogen-473 ± 210 ng/mL, P < .05

Randomized trial24 weeks34 peoplePrediabetes and dyslipidaemiaDiabetes, obesity & metabolism, Apr 20, 2023

up: Increases oocytes retrieved14.60 ± 7.79 vs. 9.84 ± 6.44

Randomized trial12 weeks50 peopleWomen20 to 40 years oldInfertile endometriosis patients presenting for ARTFrontiers in endocrinology, Mar 20, 2023

down: Decreases carbohydrate oxidation

down: Decreases heart rate-7%

no change: Has no effect on fat oxidationp > 0.05

Trial4 weeks19 people27.5 ± 6.3 yearsPatient cohortsInternational journal of exercise science, Feb 1, 2023

up: Increases walking distance

down: Decreases d-ROMs

down: Decreases blood lactate

Trial16 weeks30 people67 to 94Healthy elderly adults living in nursing homesInternational journal of environmental research and public health, Oct 18, 2022

down: Decreases glucose

no change: Has no effect on HbA1c

down: Decreases malondialdehyde-modified low-density lipoprotein87.3 ± 28.6 vs. 76.3 ± 24.6 U/L

Randomized trial12 weeks53 peopleHealthy subjects and subjects with prediabetesNutrients, Dec 7, 2021

no change: Has no effect on muscle endurance

up: Improves exercise efficiency

Randomized trial12 weeks58 people17 males and 23 femalesbetween the ages of 65 and 82Healthy without serious chronic conditions, able to perform activities of daily living without assistancePhysiological reports, Jun 1, 2021

down: Decreases malondialdehydeP < .05

down: Decreases IL-6P < .05

Randomized trial8 weeks44 peopleIn patients with type 2 diabetes mellitusInternational journal of clinical practice, Feb 2, 2021

up: Increases astaxanthin~ 20 fold

Randomized trial4 weeks32 peopleaged from 60 to 70 yearsCaucasian males or females aged from 60 to 70 years seropositive for markers of inflammation and oxidationThe journal of nutrition, health & aging, Jan 1, 2018

up: Increases adiponectin

down: Decreases visceral body fat massp<0.01

down: Decreases systolic blood pressurep<0.05

Randomized trial8 weeks44 peopleType 2 diabetes mellitusAsia Pacific journal of clinical nutrition, Jan 1, 2018

no change: Has no effect on arterial stiffness+6.0% vs +9.5% placebo

Randomized trial1 y61 peopleIn renal transplant recipientsThe American journal of clinical nutrition, Dec 16, 2015

no change: Has no effect on endurance performancefrom 238 ± 6 to 244 ± 6 W in the ASTA group (P = 0.63)

Randomized trial4 wk32 peopleMen25 ± 1 yrMedicine and science in sports and exercise, Jun 1, 2013

down: Decreases LDL cholesterol

down: Decreases malondialdehyde

Randomized trial12 weeks27 peopleadultWithin the astaxanthin group, compared with baselinePlant foods for human nutrition (Dordrecht, Netherlands), Nov 1, 2011

up: Increases HDL-C

down: Decreases triglyceride

up: Increases adiponectin

Randomized trial12 weeks61 people25-60 yearsMild hyperlipidemiaAtherosclerosis, Oct 14, 2009

up: Increases astaxanthin0.032 pmol/L, p < 0.001

down: Decreases hydroxy fatty acidsp = 0.048 and p = 0.047

Randomized trial3 monthsMen19-33 yearsGeneral population; healthy non-smokingInternational journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, Jan 1, 2007

up: Increases LDL oxidation lag time31.5, 45.4, 65.0 min versus control 19.9 min

Trial14 days in volunteers24 peoplemean age 28.2 [SD 7.8] yearsCell-free in vitro LDL oxidation induced by 400 microM V-70Journal of atherosclerosis and thrombosis, Jan 1, 2000